Diligence memo · auto-generated · as of July 2, 2026
Neurogami Medical, Inc.
Neurogami Medical, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Neurogami Medical, Inc. operates in Healthtech, based in MOUNTAIN VIEW.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Neurogami Medical, Inc. has raised $8.0M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $4.7M on 2018-05-18.
Most recent recorded round closed around 2022-02-18.
Valuation (modeled)modeled
Provath models Neurogami Medical, Inc. at approximately $22M (range $2.4M–$84M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.54× the median modeled value of Series A Healthtech companies in 2022–2024 (190 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 23 months.
Last raise 4.4 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 2.6× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 65% of Healthtech peers (2138 compared).
Modeled value ranks above 47% of those peers.
Closest niche peers: Nayya Health, Inc., Nue Life Health Inc., W Health Studio, Inc., Avant-garde Health, Inc., Kinetik Healthcare Solutions, Inc.
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.